Quince Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2017 | — | — | $7.4M |
| Mar 2018 | — | — | $4.4M |
| Jun 2018 | — | — | $77.5M |
| Sep 2018 | — | — | $27.3M |
| Dec 2018 | $1.5M | $72.9M | $24.9M |
| Mar 2019 | $4.5M | $70.6M | $20.6M |
| Jun 2019 | $7.0M | $143.2M | $44.3M |
| Sep 2019 | $6.1M | $133.4M | $44.7M |
| Dec 2019 | $8.9M | $124.4M | $51.2M |
| Mar 2020 | $13.2M | $231.2M | $85.6M |
| Jun 2020 | $13.7M | $219.2M | $66.2M |
| Sep 2020 | $16.7M | $204.7M | $64.2M |
| Dec 2020 | $17.2M | $189.5M | $66.8M |
| Mar 2021 | $18.0M | $174.5M | $85.3M |
| Jun 2021 | $19.3M | $161.4M | $74.0M |
| Sep 2021 | $14.8M | $147.4M | $62.2M |
| Dec 2021 | $14.6M | $133.2M | $29.5M |
| Mar 2022 | $9.8M | $116.1M | $40.2M |
| Jun 2022 | $6.3M | $117.9M | $33.5M |
| Sep 2022 | $5.2M | $109.8M | $21.6M |
| Dec 2022 | $3.3M | $103.9M | $40.6M |
| Mar 2023 | $3.1M | $93.3M | $42.3M |
| Jun 2023 | $2.0M | $88.8M | $20.6M |
| Sep 2023 | $2.3M | $85.4M | $20.8M |
| Dec 2023 | $82.8M | $167.9M | $20.8M |
| Mar 2024 | $85.1M | $159.3M | $21.8M |
| Jun 2024 | $87.9M | $134.8M | $7.9M |
| Sep 2024 | $81.6M | $126.5M | $2.7M |
| Dec 2024 | $84.3M | $114.5M | $6.2M |
| Mar 2025 | $88.5M | $107.1M | $7.8M |
| Jun 2025 | $105.5M | $117.2M | $16.8M |
| Sep 2025 | $108.8M | $109.9M | $6.5M |
| Dec 2025 | $129.2M | $93.5M | $5.8M |
| Mar 2026 | $11.0M | $26.6M | $18.2M |
| Jun 2026 | $15.5M | $124.0M | $116.0M |